Zhihua Ma

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
Taken 37 bio-pharmaceutical companies on SME board in China, this papers constructs a growth evaluation indicator system for these companies by operating income growth rate, net profits, sales net profit, returns on total asset, ROE, debt to equity, current ratio, working capital ratio, turnover of current asset, and turnover of total asset. By way of(More)
  • 1